0001214659-23-010670.txt : 20230802
0001214659-23-010670.hdr.sgml : 20230802
20230802170013
ACCESSION NUMBER: 0001214659-23-010670
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230724
FILED AS OF DATE: 20230802
DATE AS OF CHANGE: 20230802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Agafonova Nataliya
CENTRAL INDEX KEY: 0001985443
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40060
FILM NUMBER: 231136707
MAIL ADDRESS:
STREET 1: 1951 NW 7TH AVENUE
CITY: MIAMI
STATE: FL
ZIP: 33136
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Longeveron Inc.
CENTRAL INDEX KEY: 0001721484
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472174146
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1951 NW 7TH AVENUE
STREET 2: SUITE 520
CITY: MIAMI
STATE: FL
ZIP: 33136
BUSINESS PHONE: 305-302-7158
MAIL ADDRESS:
STREET 1: 1951 NW 7TH AVENUE
STREET 2: SUITE 520
CITY: MIAMI
STATE: FL
ZIP: 33136
FORMER COMPANY:
FORMER CONFORMED NAME: LONGEVERON LLC
DATE OF NAME CHANGE: 20171101
4
1
marketforms-62164.xml
PRIMARY DOCUMENT
X0508
4
2023-07-24
0001721484
Longeveron Inc.
LGVN
0001985443
Agafonova Nataliya
1951 NW 7TH AVENUE, SUITE 520
MIAMI
FL
33136
false
true
false
false
Chief Medical Officer
0
Common Stock
2023-07-24
4
A
false
30000
0
A
30000
D
Represents the award of 30,000 Restricted Stock Units, which vest 25% on each of the award date, October 1, 2023, January 1, 2024, and April 1, 2024.
Includes 22,500 Restricted Stock Units.
/s/ Paul Lehr, attorney-in-fact
2023-08-01